Amri Italy S.r.l.

Euticals Spa

Curia IP Holdings, LLC

Emanuela Fumagalli

Maria Argese

Paride Grisenti

Giuseppe Motta

Daniele Pengo

Maria Donata Grilli

A Rifaximin polymorphic mixture of &#x3b1;/&#x3b2; form in a relative ratio of 85/15&#xb1;3 and a process for its preparation. The polymorphic mixture of Rifaximin is for use as a medicament, in particular in the treatment of traveler's diarrhea and hepatic encephalopathy. A pharmaceutical composition comprises the polymorphic mixture of Rifaximin as active ingredient, in particular, a solid formulation, more in particular, a film coated tablet. A polymorphic form of crude wet rifaximin and of purified wet rifaximin their use are used as intermediates in a process for the preparation of Rifaximin polymorphic mixture of &#x3b1;/&#x3b2; form in a relative ratio of 85/15&#xb1;3.

Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations

Polymorphic mixture of rifaximin and its use for the preparation of solid formulations

Growing community of inventors

Lainate, Italy

Emanuela Fumagalli